Fe₃O₄ Nanoparticles for Complex Targeted Delivery and Boron Neutron Capture Therapy

Kanat Dukenbayev, Ilya V. Korolkov, Daria I. Tishkevich, Artem L. Kozlovskiy, Sergey V. Trukhanov, Yevgeniy G. Gorin, Elena E. Shumskaya, Egor Y. Kaniukov, Denis A. Vinnik, Maxim V. Zdorovets, Marina Anisovich, Alex V. Trukhanov, Daniele Tosi, Carlo Molardi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Magnetic Fe 3 O 4 nanoparticles (NPs) and their surface modification with therapeutic substances are of great interest, especially drug delivery for cancer therapy, including boron-neutron capture therapy (BNCT). In this paper, we present the results of boron-rich compound (carborane borate) attachment to previously aminated by (3-aminopropyl)-trimethoxysilane (APTMS) iron oxide NPs. Fourier transform infrared spectroscopy with Attenuated total reflectance accessory (ATR-FTIR) and energy-dispersive X-ray analysis confirmed the change of the element content of NPs after modification and formation of new bonds between Fe3O4 NPs and the attached molecules. Transmission (TEM) and scanning electron microscopy (SEM) showed Fe3O4 NPs’ average size of 18.9 nm. Phase parameters were studied by powder X-ray diffraction (XRD), and the magnetic behavior of Fe 3 O 4 NPs was elucidated by Mössbauer spectroscopy. The colloidal and chemical stability of NPs was studied using simulated body fluid (phosphate buffer-PBS). Modified NPs have shown excellent stability in PBS (pH = 7.4), characterized by XRD, Mössbauer spectroscopy, and dynamic light scattering (DLS). Biocompatibility was evaluated in-vitro using cultured mouse embryonic fibroblasts (MEFs). The results show us an increasing of IC50 from 0.110 mg/mL for Fe 3 O 4 NPs to 0.405 mg/mL for Fe 3 O 4 -Carborane NPs. The obtained data confirm the biocompatibility and stability of synthesized NPs and the potential to use them in BNCT.

Original languageEnglish
Article number494
JournalNanomaterials
Volume9
Issue number4
DOIs
Publication statusPublished - Apr 1 2019

Fingerprint

Boron
Neutrons
Nanoparticles
Biocompatibility
Spectroscopy
Borates
Energy dispersive X ray analysis
Body fluids
Chemical stability
Accessories
Dynamic light scattering
Fibroblasts
Drug delivery
Iron oxides
X ray powder diffraction
Fourier transform infrared spectroscopy
Surface treatment
Buffers
Phosphates
Transmission electron microscopy

Keywords

  • APTMS
  • Carborane
  • Iron oxide
  • Magnetic nanoparticles
  • Surface functionalization

ASJC Scopus subject areas

  • Chemical Engineering(all)
  • Materials Science(all)

Cite this

Fe₃O₄ Nanoparticles for Complex Targeted Delivery and Boron Neutron Capture Therapy. / Dukenbayev, Kanat; Korolkov, Ilya V.; Tishkevich, Daria I.; Kozlovskiy, Artem L.; Trukhanov, Sergey V.; Gorin, Yevgeniy G.; Shumskaya, Elena E.; Kaniukov, Egor Y.; Vinnik, Denis A.; Zdorovets, Maxim V.; Anisovich, Marina; Trukhanov, Alex V.; Tosi, Daniele; Molardi, Carlo.

In: Nanomaterials, Vol. 9, No. 4, 494, 01.04.2019.

Research output: Contribution to journalArticle

Dukenbayev, K, Korolkov, IV, Tishkevich, DI, Kozlovskiy, AL, Trukhanov, SV, Gorin, YG, Shumskaya, EE, Kaniukov, EY, Vinnik, DA, Zdorovets, MV, Anisovich, M, Trukhanov, AV, Tosi, D & Molardi, C 2019, 'Fe₃O₄ Nanoparticles for Complex Targeted Delivery and Boron Neutron Capture Therapy', Nanomaterials, vol. 9, no. 4, 494. https://doi.org/10.3390/nano9040494, https://doi.org/10.3390/nano9040494
Dukenbayev, Kanat ; Korolkov, Ilya V. ; Tishkevich, Daria I. ; Kozlovskiy, Artem L. ; Trukhanov, Sergey V. ; Gorin, Yevgeniy G. ; Shumskaya, Elena E. ; Kaniukov, Egor Y. ; Vinnik, Denis A. ; Zdorovets, Maxim V. ; Anisovich, Marina ; Trukhanov, Alex V. ; Tosi, Daniele ; Molardi, Carlo. / Fe₃O₄ Nanoparticles for Complex Targeted Delivery and Boron Neutron Capture Therapy. In: Nanomaterials. 2019 ; Vol. 9, No. 4.
@article{adfc65f1efc949ef867e8f4f727cebbf,
title = "Fe₃O₄ Nanoparticles for Complex Targeted Delivery and Boron Neutron Capture Therapy",
abstract = "Magnetic Fe 3 O 4 nanoparticles (NPs) and their surface modification with therapeutic substances are of great interest, especially drug delivery for cancer therapy, including boron-neutron capture therapy (BNCT). In this paper, we present the results of boron-rich compound (carborane borate) attachment to previously aminated by (3-aminopropyl)-trimethoxysilane (APTMS) iron oxide NPs. Fourier transform infrared spectroscopy with Attenuated total reflectance accessory (ATR-FTIR) and energy-dispersive X-ray analysis confirmed the change of the element content of NPs after modification and formation of new bonds between Fe3O4 NPs and the attached molecules. Transmission (TEM) and scanning electron microscopy (SEM) showed Fe3O4 NPs’ average size of 18.9 nm. Phase parameters were studied by powder X-ray diffraction (XRD), and the magnetic behavior of Fe 3 O 4 NPs was elucidated by M{\"o}ssbauer spectroscopy. The colloidal and chemical stability of NPs was studied using simulated body fluid (phosphate buffer-PBS). Modified NPs have shown excellent stability in PBS (pH = 7.4), characterized by XRD, M{\"o}ssbauer spectroscopy, and dynamic light scattering (DLS). Biocompatibility was evaluated in-vitro using cultured mouse embryonic fibroblasts (MEFs). The results show us an increasing of IC50 from 0.110 mg/mL for Fe 3 O 4 NPs to 0.405 mg/mL for Fe 3 O 4 -Carborane NPs. The obtained data confirm the biocompatibility and stability of synthesized NPs and the potential to use them in BNCT.",
keywords = "APTMS, Carborane, Iron oxide, Magnetic nanoparticles, Surface functionalization",
author = "Kanat Dukenbayev and Korolkov, {Ilya V.} and Tishkevich, {Daria I.} and Kozlovskiy, {Artem L.} and Trukhanov, {Sergey V.} and Gorin, {Yevgeniy G.} and Shumskaya, {Elena E.} and Kaniukov, {Egor Y.} and Vinnik, {Denis A.} and Zdorovets, {Maxim V.} and Marina Anisovich and Trukhanov, {Alex V.} and Daniele Tosi and Carlo Molardi",
year = "2019",
month = "4",
day = "1",
doi = "10.3390/nano9040494",
language = "English",
volume = "9",
journal = "Nanomaterials",
issn = "2079-4991",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

TY - JOUR

T1 - Fe₃O₄ Nanoparticles for Complex Targeted Delivery and Boron Neutron Capture Therapy

AU - Dukenbayev, Kanat

AU - Korolkov, Ilya V.

AU - Tishkevich, Daria I.

AU - Kozlovskiy, Artem L.

AU - Trukhanov, Sergey V.

AU - Gorin, Yevgeniy G.

AU - Shumskaya, Elena E.

AU - Kaniukov, Egor Y.

AU - Vinnik, Denis A.

AU - Zdorovets, Maxim V.

AU - Anisovich, Marina

AU - Trukhanov, Alex V.

AU - Tosi, Daniele

AU - Molardi, Carlo

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Magnetic Fe 3 O 4 nanoparticles (NPs) and their surface modification with therapeutic substances are of great interest, especially drug delivery for cancer therapy, including boron-neutron capture therapy (BNCT). In this paper, we present the results of boron-rich compound (carborane borate) attachment to previously aminated by (3-aminopropyl)-trimethoxysilane (APTMS) iron oxide NPs. Fourier transform infrared spectroscopy with Attenuated total reflectance accessory (ATR-FTIR) and energy-dispersive X-ray analysis confirmed the change of the element content of NPs after modification and formation of new bonds between Fe3O4 NPs and the attached molecules. Transmission (TEM) and scanning electron microscopy (SEM) showed Fe3O4 NPs’ average size of 18.9 nm. Phase parameters were studied by powder X-ray diffraction (XRD), and the magnetic behavior of Fe 3 O 4 NPs was elucidated by Mössbauer spectroscopy. The colloidal and chemical stability of NPs was studied using simulated body fluid (phosphate buffer-PBS). Modified NPs have shown excellent stability in PBS (pH = 7.4), characterized by XRD, Mössbauer spectroscopy, and dynamic light scattering (DLS). Biocompatibility was evaluated in-vitro using cultured mouse embryonic fibroblasts (MEFs). The results show us an increasing of IC50 from 0.110 mg/mL for Fe 3 O 4 NPs to 0.405 mg/mL for Fe 3 O 4 -Carborane NPs. The obtained data confirm the biocompatibility and stability of synthesized NPs and the potential to use them in BNCT.

AB - Magnetic Fe 3 O 4 nanoparticles (NPs) and their surface modification with therapeutic substances are of great interest, especially drug delivery for cancer therapy, including boron-neutron capture therapy (BNCT). In this paper, we present the results of boron-rich compound (carborane borate) attachment to previously aminated by (3-aminopropyl)-trimethoxysilane (APTMS) iron oxide NPs. Fourier transform infrared spectroscopy with Attenuated total reflectance accessory (ATR-FTIR) and energy-dispersive X-ray analysis confirmed the change of the element content of NPs after modification and formation of new bonds between Fe3O4 NPs and the attached molecules. Transmission (TEM) and scanning electron microscopy (SEM) showed Fe3O4 NPs’ average size of 18.9 nm. Phase parameters were studied by powder X-ray diffraction (XRD), and the magnetic behavior of Fe 3 O 4 NPs was elucidated by Mössbauer spectroscopy. The colloidal and chemical stability of NPs was studied using simulated body fluid (phosphate buffer-PBS). Modified NPs have shown excellent stability in PBS (pH = 7.4), characterized by XRD, Mössbauer spectroscopy, and dynamic light scattering (DLS). Biocompatibility was evaluated in-vitro using cultured mouse embryonic fibroblasts (MEFs). The results show us an increasing of IC50 from 0.110 mg/mL for Fe 3 O 4 NPs to 0.405 mg/mL for Fe 3 O 4 -Carborane NPs. The obtained data confirm the biocompatibility and stability of synthesized NPs and the potential to use them in BNCT.

KW - APTMS

KW - Carborane

KW - Iron oxide

KW - Magnetic nanoparticles

KW - Surface functionalization

UR - http://www.scopus.com/inward/record.url?scp=85065228757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065228757&partnerID=8YFLogxK

U2 - 10.3390/nano9040494

DO - 10.3390/nano9040494

M3 - Article

VL - 9

JO - Nanomaterials

JF - Nanomaterials

SN - 2079-4991

IS - 4

M1 - 494

ER -